Diamyd Medical AB (publ) (STO:DMYD.B)
Sweden · Delayed Price · Currency is SEK 1.032
+0.002 (0.19%)
Jul 24, 2026, 5:29 PM CET
Diamyd Medical AB Income Statement
Financials in millions SEK. Fiscal year is September - August.
Millions SEK. Fiscal year is Sep - Aug.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 |
| 4.12 | 5.02 | 4.36 | 3.75 | 2.59 | 0.44 | |
Revenue Growth (YoY) | -25.25% | 14.92% | 16.47% | 44.95% | 482.21% | -99.00% |
Gross Profit | 4.12 | 5.02 | 4.36 | 3.75 | 2.59 | 0.44 |
Selling, General & Admin | 68.67 | 56.55 | 44.79 | 39.7 | 31.93 | 25.63 |
Depreciation & Amortization Expenses | 7.05 | 6.5 | 10.99 | 4.87 | 4.38 | 0.78 |
Research & Development | 214.45 | 123.34 | 100.19 | 73.54 | 79.97 | 59.36 |
Other Operating Expenses | 1.52 | 1.86 | -5.04 | 6.45 | 4.48 | 0.55 |
Total Operating Expenses | 291.69 | 188.25 | 150.93 | 124.55 | 120.76 | 86.33 |
Operating Income | -287.57 | -183.24 | -146.57 | -120.81 | -118.18 | -85.88 |
Interest Income | 6.33 | 10.2 | 6 | 4.74 | 8.26 | 1.97 |
Interest Expense | -1.63 | -3.7 | -2.14 | -0 | -0.25 | -0.45 |
Other Non-Operating Income (Expense) | -0.78 | 6.96 | -9.14 | - | 6.65 | 144.41 |
Total Non-Operating Income (Expense) | 3.93 | 13.46 | -5.28 | 4.73 | 14.66 | 145.93 |
Pretax Income | -93.71 | -169.78 | -151.85 | -116.07 | -103.52 | 60.05 |
Net Income | -93.71 | -169.78 | -151.85 | -116.07 | -103.52 | 60.05 |
Net Income to Common | -283.65 | -169.78 | -151.85 | -116.07 | -103.52 | 60.05 |
Net Income Growth | - | - | - | - | - | 518.46% |
Shares Outstanding (Basic) | 141 | 113 | 95 | 78 | 77 | 70 |
Shares Outstanding (Diluted) | 141 | 113 | 95 | 78 | 77 | 70 |
Shares Change (YoY) | 36.67% | 18.81% | 20.98% | 2.29% | 9.65% | 0.90% |
EPS (Basic) | -1.80 | -1.50 | -1.60 | -1.50 | -1.40 | 0.90 |
EPS (Diluted) | -1.80 | -1.50 | -1.60 | -1.50 | -1.40 | 0.90 |
EPS Growth | - | - | - | - | - | 800.00% |
Free Cash Flow | -194.03 | -179.73 | -137.21 | -122.4 | -127.87 | -113.69 |
Free Cash Flow Per Share | -1.38 | -1.60 | -1.45 | -1.56 | -1.67 | -1.63 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | -6983.29% | -3653.76% | -3358.55% | -3224.07% | -4571.61% | -19342.30% |
Profit Margin | -2275.57% | -3385.38% | -3479.61% | -3097.76% | -4004.53% | 13523.90% |
FCF Margin | -4711.63% | -3583.87% | -3144.04% | -3266.72% | -4946.65% | -25606.50% |
EBITDA | -280.63 | -176.73 | -135.58 | -115.94 | -113.79 | -85.1 |
EBITDA Margin | -6814.79% | -3524.07% | -3106.69% | -3094.13% | -4402.05% | -19166.20% |
EBIT | -287.57 | -183.24 | -146.57 | -120.81 | -118.18 | -85.88 |
EBIT Margin | -6983.29% | -3653.76% | -3358.55% | -3224.07% | -4571.61% | -19342.30% |